Trial Profile
Efficacy of drug-eluating stents in patients with chronic total coronary occlusion: An observational results from SCAAR registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Paclitaxel (Primary) ; Sirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 07 Feb 2017 New trial record